Suspension from Quotation
Open PDF
| Stock | Adheris Health Limited (AHE.ASX) |
|---|---|
| Release Time | 1 Oct 2025, 9:27 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Medadvisor Ltd suspended from ASX quotation
Key Points
- Medadvisor Ltd suspended from ASX quotation
- Suspension due to not lodging relevant periodic report by due date
- Securities may be reinstated if report is lodged before market close on 30 September
Full Summary
Medadvisor Ltd has been suspended from quotation on the Australian Securities Exchange (ASX) under Listing Rule 17.5. The suspension is due to the company not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Tuesday, 30 September 2025, and the imposition of the suspension, the company's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. The suspension affects a number of other companies as well, including ActivEX Limited, Admiralty Resources NL, ASF Group Limited, and others. The announcement provides the full list of companies impacted by the suspension.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In